These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 3580573
41. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma. Metha BA, Advani SH, Nadkarni SJ. Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838 [Abstract] [Full Text] [Related]
42. Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF). Marubayashi M, Solana R, Ramirez R, Aranda E, Galan F, Peña J. Br J Cancer; 1991 Jun; 63(6):893-6. PubMed ID: 1906292 [Abstract] [Full Text] [Related]
44. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients. Ramsey KM, Djeu JY, Rook AH. Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061 [Abstract] [Full Text] [Related]
45. Purification and target cell range of in vivo elicited blast natural killer cells. Biron CA, Pedersen KF, Welsh RM. J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814 [Abstract] [Full Text] [Related]
46. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay. Wahlberg BJ, Burholt DR, Kornblith P, Richards TJ, Bruffsky A, Herberman RB, Vujanovic NL. J Immunol Methods; 2001 Jul 01; 253(1-2):69-81. PubMed ID: 11384670 [Abstract] [Full Text] [Related]
47. Effects of X-ray irradiation on natural killer (NK) cell system. II. Increased sensitivity to natural killer cytotoxic factor (NKCF). Uchida A, Mizutani Y, Nagamuta M, Ikenaga M. Immunopharmacol Immunotoxicol; 1989 Jul 01; 11(2-3):521-34. PubMed ID: 2621326 [Abstract] [Full Text] [Related]
48. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay. Kim GG, Donnenberg VS, Donnenberg AD, Gooding W, Whiteside TL. J Immunol Methods; 2007 Aug 31; 325(1-2):51-66. PubMed ID: 17617419 [Abstract] [Full Text] [Related]
49. Mechanism of inhibition of natural killing by a glycopeptide isolated from the K562 plasma membrane. Targan S, Decker JM, Ades EW. Nat Immun Cell Growth Regul; 2007 Aug 31; 3(3):113-23. PubMed ID: 6438498 [Abstract] [Full Text] [Related]
50. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays. Gregory CD, Lee H, Rees GB, Scott IV, Shah LP, Golding PR. Clin Exp Immunol; 1985 Oct 31; 62(1):121-7. PubMed ID: 3864569 [Abstract] [Full Text] [Related]
51. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin. Ortaldo JR, Ransom JR, Sayers TJ, Herberman RB. J Immunol; 1986 Nov 01; 137(9):2857-63. PubMed ID: 3093586 [Abstract] [Full Text] [Related]
52. Mechanisms of diminished natural killer cell activity in pregnant women and neonates. Baley JE, Schacter BZ. J Immunol; 1985 May 01; 134(5):3042-8. PubMed ID: 3980989 [Abstract] [Full Text] [Related]
53. Induction of lymphokine-activated killer and natural killer cell activities from cryopreserved lymphocytes. Kawai H, Komiyama A, Katoh M, Yabuhara A, Miyagawa Y, Akabane T. Transfusion; 1988 May 01; 28(6):531-5. PubMed ID: 3264091 [Abstract] [Full Text] [Related]
54. Increased number of functionally defective large granular lymphocytes in lymphoma patients. Muhonen T, Teerenhovi L, Saksela E. Nat Immun Cell Growth Regul; 1987 May 01; 6(2):57-64. PubMed ID: 3600676 [Abstract] [Full Text] [Related]
55. Relevance of soluble cytotoxic factors generated by mycoplasma-contaminated targets to natural killer cell-mediated killing. Hommel-Berrey GA, Brahmi Z. Hum Immunol; 1987 Sep 01; 20(1):33-46. PubMed ID: 3679901 [Abstract] [Full Text] [Related]
56. Effects of maximal exercise on natural killer (NK) cell cytotoxicity and responsiveness to interferon-alpha in the young and old. Woods JA, Evans JK, Wolters BW, Ceddia MA, McAuley E. J Gerontol A Biol Sci Med Sci; 1998 Nov 01; 53(6):B430-7. PubMed ID: 9823739 [Abstract] [Full Text] [Related]
57. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit. Hiserodt JC, Britvan L, Targan SR. J Immunol; 1983 Dec 01; 131(6):2705-9. PubMed ID: 6358352 [Abstract] [Full Text] [Related]
58. Human natural killer cytotoxic factor (NKCF): role of IFN-alpha. Steinhauer EH, Doyle AT, Kadish AS. J Immunol; 1985 Jul 01; 135(1):294-9. PubMed ID: 3998466 [Abstract] [Full Text] [Related]
59. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells. Mizutani Y, Bonavida B, Nio Y, Yoshida O. Cancer; 1993 Feb 15; 71(4):1313-21. PubMed ID: 7679609 [Abstract] [Full Text] [Related]
60. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells. Duke RC, Cohen JJ, Chervenak R. J Immunol; 1986 Sep 01; 137(5):1442-7. PubMed ID: 2943792 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]